AU2021100406A4 - The Clear Co Ear Cleanser - Google Patents

The Clear Co Ear Cleanser Download PDF

Info

Publication number
AU2021100406A4
AU2021100406A4 AU2021100406A AU2021100406A AU2021100406A4 AU 2021100406 A4 AU2021100406 A4 AU 2021100406A4 AU 2021100406 A AU2021100406 A AU 2021100406A AU 2021100406 A AU2021100406 A AU 2021100406A AU 2021100406 A4 AU2021100406 A4 AU 2021100406A4
Authority
AU
Australia
Prior art keywords
ear
clear
cleanser
earwax
hydrogen peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021100406A
Inventor
James Pennington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clear Co
Original Assignee
Clear Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clear Co filed Critical Clear Co
Priority to AU2021100406A priority Critical patent/AU2021100406A4/en
Application granted granted Critical
Publication of AU2021100406A4 publication Critical patent/AU2021100406A4/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0046Ear
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Detergent Compositions (AREA)

Abstract

This invention is relates to a composition of hydrogen peroxide, preferably 3%, for aural administration to breakdown and dissolve earwax, removing ear blockages and water emulsions.

Description

The Clear Co Ear Cleanser - Description
The Clear Co Ear Cleanser has been specifically formulated to assist with the dissolving and removing of excess earwax that may be causing blockages and other problems.
The active ingredient in this product is 3% Hydrogen Peroxide which is a cerumenolytic, meaning that it can soften, breakdown and dissolve earwax. It is administered to the entry of the ear canal using a dropper bottle.
Page 1 of 1
The Clear Co Ear Cleanser - Claims
The Clear Co Ear Cleanser dissolves earwax and assists in removing ear blockages and water emulsions.
Hydrogen Peroxide solutions can come in many different formulations each targeted to a specific use. Many contain additives, such as stabilisers, reducing the effectiveness of the solution for ear wax removal.
With the advice and assistance from chemists, pharmacists and medical experts, this unique solution uses a low concentration of Hydrogen Peroxide to ensure there are no harmful effects. You will notice a reaction when adding the drops to your ear as you will hear a crackling or bubbling sound.
Page 1 of 1
AU2021100406A 2021-01-22 2021-01-22 The Clear Co Ear Cleanser Active AU2021100406A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021100406A AU2021100406A4 (en) 2021-01-22 2021-01-22 The Clear Co Ear Cleanser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2021100406A AU2021100406A4 (en) 2021-01-22 2021-01-22 The Clear Co Ear Cleanser

Publications (1)

Publication Number Publication Date
AU2021100406A4 true AU2021100406A4 (en) 2021-04-15

Family

ID=75397192

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021100406A Active AU2021100406A4 (en) 2021-01-22 2021-01-22 The Clear Co Ear Cleanser

Country Status (1)

Country Link
AU (1) AU2021100406A4 (en)

Similar Documents

Publication Publication Date Title
MX2009009623A (en) Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors.
AR035569A1 (en) PROCESS AND COMPOSITION FOR CLEANING MEDICAL INSTRUMENTS
CN101454008B (en) Dental appliance cleanser
DK1079804T3 (en) Pharmaceutical compositions containing an amorphous surfactant, a polypropoxylated cetyl alcohol and a polar drug
Niezgoda et al. Evaluation of Vashe Wound Therapy in the clinical management of patients with chronic wounds
AU2021100406A4 (en) The Clear Co Ear Cleanser
MA46229A (en) HETERARYL CARBOXAMIDE COMPOUNDS AS RIPK2 INHIBITORS
US20140287064A1 (en) Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument
US20140357600A1 (en) Novel ester containing compositions and methods
ATE322244T1 (en) USE OF POLYAMINO ACID DERIVATIVES FOR THE TREATMENT OF SEBORRHEA AND RELATED SKIN DISORDERS
JP2021165284A5 (en)
FR2869615A1 (en) BUTANOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THERAPEUTIC APPLICATIONS THEREOF
NZ592567A (en) Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients
CN101756846A (en) Oryzenin-containing face cleansing emulsion and preparation method thereof
WO2020257631A3 (en) Ppm1a inhibitors and methods of using same
MX2008010927A (en) Ccr5 antagonists useful for treating hiv.
KR101796816B1 (en) Cosmetic composition for protecting skin comprising dimethicone, acrylate, triethanolamine and bromelain
WO2008060535A3 (en) Use of reversine and analogs for treatment of cancer
FR2869610A1 (en) PENTENOIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC APPLICATIONS THEREOF
JPH09143067A (en) Therapeutic agent for atopic dermatitis
EP2456445B1 (en) Agent for the treatment of skin conditions
Tandan et al. Ozone in conservative dentistry & endodontics: A
JP3222505U (en) Lubricating lotion
JP2022025746A (en) Contact preventive agent and composition for hand/finger disinfection
JPS6327425A (en) Remedy for acne vulgaris

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK22 Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 22 JAN 2023 TO 22 OCT 2023 IN WHICH TO PAY A RENEWAL FEE HAS BEEN FILED

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 22 OCT 2023